Scribe Therapeutics
@scribetx.bsky.social
We're excited to share breakthrough preclinical data across our cardiometabolic pipeline presented at #AHA25, highlighting our comprehensive strategy to address the key drivers of #ASCVD.
Thanks to Fierce Biotech‘s Darren Incorvaia for the feature:
www.fiercebiotech.com/research/scr...
Thanks to Fierce Biotech‘s Darren Incorvaia for the feature:
www.fiercebiotech.com/research/scr...
November 17, 2025 at 6:53 PM
We're excited to share breakthrough preclinical data across our cardiometabolic pipeline presented at #AHA25, highlighting our comprehensive strategy to address the key drivers of #ASCVD.
Thanks to Fierce Biotech‘s Darren Incorvaia for the feature:
www.fiercebiotech.com/research/scr...
Thanks to Fierce Biotech‘s Darren Incorvaia for the feature:
www.fiercebiotech.com/research/scr...
Scribe CEO @benjaminloakes.bsky.social will join a fireside chat at Fierce Biotech's Cell & Gene Turning Point event on Thursday, 11/20.
He'll discuss how CRISPR-based therapies could help prevent, not just treat, cardiovascular disease.
Register for free here: www.fiercecellandgene.com
He'll discuss how CRISPR-based therapies could help prevent, not just treat, cardiovascular disease.
Register for free here: www.fiercecellandgene.com
November 11, 2025 at 6:04 PM
Scribe CEO @benjaminloakes.bsky.social will join a fireside chat at Fierce Biotech's Cell & Gene Turning Point event on Thursday, 11/20.
He'll discuss how CRISPR-based therapies could help prevent, not just treat, cardiovascular disease.
Register for free here: www.fiercecellandgene.com
He'll discuss how CRISPR-based therapies could help prevent, not just treat, cardiovascular disease.
Register for free here: www.fiercecellandgene.com
🥇 Our Computational Genomics & Data Science team won 1ST PLACE in AWS AI League for Startups SF!
Huge shout-out to champion Mohit Pandey and full squad for showcasing Scribe’s growing AI innovation capabilities. Thanks to @awscloud.bsky.social for inviting us and a fantastic competition.
Huge shout-out to champion Mohit Pandey and full squad for showcasing Scribe’s growing AI innovation capabilities. Thanks to @awscloud.bsky.social for inviting us and a fantastic competition.
November 5, 2025 at 8:31 PM
🥇 Our Computational Genomics & Data Science team won 1ST PLACE in AWS AI League for Startups SF!
Huge shout-out to champion Mohit Pandey and full squad for showcasing Scribe’s growing AI innovation capabilities. Thanks to @awscloud.bsky.social for inviting us and a fantastic competition.
Huge shout-out to champion Mohit Pandey and full squad for showcasing Scribe’s growing AI innovation capabilities. Thanks to @awscloud.bsky.social for inviting us and a fantastic competition.
📣 #AHA25 is almost here! We’re headed to New Orleans to share the latest on our pipeline of #CRISPR genome editing & epigenetic silencing therapies for cardiometabolic disease.
Details below on 4 presentations by our CSO Aarif Khakoo & SVP of Discovery Biology Maria Mirotsou 👇
Details below on 4 presentations by our CSO Aarif Khakoo & SVP of Discovery Biology Maria Mirotsou 👇
November 3, 2025 at 6:07 PM
When it’s spooky season at Scribe, expect our annual #Halloween barbecue, scary and scientific costumes, and treats galore. Happy Halloween to all! 🎃
November 1, 2025 at 12:21 AM
When it’s spooky season at Scribe, expect our annual #Halloween barbecue, scary and scientific costumes, and treats galore. Happy Halloween to all! 🎃
How can we transform the standard of care for heart disease? ❤️🩹
Join us at #TCT2025 this Saturday to hear from our CEO @benjaminloakes.bsky.social, who will share promising #CRISPR gene editing and epigenetic silencing strategies at @crfheart.bsky.social TCT MedTech Innovation Forum.
Join us at #TCT2025 this Saturday to hear from our CEO @benjaminloakes.bsky.social, who will share promising #CRISPR gene editing and epigenetic silencing strategies at @crfheart.bsky.social TCT MedTech Innovation Forum.
October 22, 2025 at 6:05 PM
How can we transform the standard of care for heart disease? ❤️🩹
Join us at #TCT2025 this Saturday to hear from our CEO @benjaminloakes.bsky.social, who will share promising #CRISPR gene editing and epigenetic silencing strategies at @crfheart.bsky.social TCT MedTech Innovation Forum.
Join us at #TCT2025 this Saturday to hear from our CEO @benjaminloakes.bsky.social, who will share promising #CRISPR gene editing and epigenetic silencing strategies at @crfheart.bsky.social TCT MedTech Innovation Forum.
Listen to Scribe’s co-founder, Jennifer Doudna, speak to the vision that Scribe was founded on – unlocking #CRISPR to revolutionize the standard of care for cardiometabolic disease.
"I really hope that gene editing technology, like CRISPR, becomes a preventative [therapy]..." 🧵
"I really hope that gene editing technology, like CRISPR, becomes a preventative [therapy]..." 🧵
October 10, 2025 at 6:42 PM
Listen to Scribe’s co-founder, Jennifer Doudna, speak to the vision that Scribe was founded on – unlocking #CRISPR to revolutionize the standard of care for cardiometabolic disease.
"I really hope that gene editing technology, like CRISPR, becomes a preventative [therapy]..." 🧵
"I really hope that gene editing technology, like CRISPR, becomes a preventative [therapy]..." 🧵
Congrats to our CEO, @benjaminloakes.bsky.social, on being named to BioSpace’s inaugural 40 Under 40 list of exemplary biotech leaders for his vision, innovation, and commitment to advancing next-generation #CRISPR-based therapeutics that improve patient outcomes.
October 7, 2025 at 4:32 PM
Congrats to our CEO, @benjaminloakes.bsky.social, on being named to BioSpace’s inaugural 40 Under 40 list of exemplary biotech leaders for his vision, innovation, and commitment to advancing next-generation #CRISPR-based therapeutics that improve patient outcomes.
We’re headed to #ESGCT2025 to share our latest #CRISPR #EpigeneticEditing data. Check out our presentation on Thursday, Oct. 9!
🧬 Engineering enhanced epigenetic editors: novel repressor domains drive potent and durable therapeutic gene silencing in non-human primates
🧬 Engineering enhanced epigenetic editors: novel repressor domains drive potent and durable therapeutic gene silencing in non-human primates
October 6, 2025 at 5:01 PM
We’re headed to #ESGCT2025 to share our latest #CRISPR #EpigeneticEditing data. Check out our presentation on Thursday, Oct. 9!
🧬 Engineering enhanced epigenetic editors: novel repressor domains drive potent and durable therapeutic gene silencing in non-human primates
🧬 Engineering enhanced epigenetic editors: novel repressor domains drive potent and durable therapeutic gene silencing in non-human primates
Meet Scribe at #CGMesa25 in Phoenix 🌵
Our CFO David Parrot will be onsite at the @alliancerm.bsky.social Cell & Gene Meeting on the Mesa to present updates on our work engineering #CRISPR-based medicines for cardiometabolic disease.
Swing by and learn more on Monday, Oct. 6 at 1:45pm MST.
Our CFO David Parrot will be onsite at the @alliancerm.bsky.social Cell & Gene Meeting on the Mesa to present updates on our work engineering #CRISPR-based medicines for cardiometabolic disease.
Swing by and learn more on Monday, Oct. 6 at 1:45pm MST.
October 3, 2025 at 7:40 PM
Meet Scribe at #CGMesa25 in Phoenix 🌵
Our CFO David Parrot will be onsite at the @alliancerm.bsky.social Cell & Gene Meeting on the Mesa to present updates on our work engineering #CRISPR-based medicines for cardiometabolic disease.
Swing by and learn more on Monday, Oct. 6 at 1:45pm MST.
Our CFO David Parrot will be onsite at the @alliancerm.bsky.social Cell & Gene Meeting on the Mesa to present updates on our work engineering #CRISPR-based medicines for cardiometabolic disease.
Swing by and learn more on Monday, Oct. 6 at 1:45pm MST.
Ahead of #WorldHeartDay, Taylor Swift recently raised an important reminder: heart disease is the leading cause of death, and one person dies from it every 34 seconds.
For some, including her father, a routine stress test revealed severe disease early enough to undergo surgery.
For some, including her father, a routine stress test revealed severe disease early enough to undergo surgery.
September 30, 2025 at 12:25 AM
Ahead of #WorldHeartDay, Taylor Swift recently raised an important reminder: heart disease is the leading cause of death, and one person dies from it every 34 seconds.
For some, including her father, a routine stress test revealed severe disease early enough to undergo surgery.
For some, including her father, a routine stress test revealed severe disease early enough to undergo surgery.
Attending the Genome Editing Therapeutics Summit?
Join us Sept. 30 for the opening presentation by Kai-Yuan Chen, Scribe's Director of Data Science & Tech Platform, highlighting DeepXE: our deep learning model powering #CRISPR-CasX therapeutic gRNA design.
#AI #MachineLearning
Join us Sept. 30 for the opening presentation by Kai-Yuan Chen, Scribe's Director of Data Science & Tech Platform, highlighting DeepXE: our deep learning model powering #CRISPR-CasX therapeutic gRNA design.
#AI #MachineLearning
September 26, 2025 at 5:04 PM
Attending the Genome Editing Therapeutics Summit?
Join us Sept. 30 for the opening presentation by Kai-Yuan Chen, Scribe's Director of Data Science & Tech Platform, highlighting DeepXE: our deep learning model powering #CRISPR-CasX therapeutic gRNA design.
#AI #MachineLearning
Join us Sept. 30 for the opening presentation by Kai-Yuan Chen, Scribe's Director of Data Science & Tech Platform, highlighting DeepXE: our deep learning model powering #CRISPR-CasX therapeutic gRNA design.
#AI #MachineLearning
This Thursday, join us at the Oppenheimer Private Life Science Company Showcase for a virtual presentation by our CFO David Parrot.
📅 September 25, 2025
🕗 3:15pm ET
📍 Virtual
✅ Register for the event or reach out to our team at www.scribetx.com/contact
📅 September 25, 2025
🕗 3:15pm ET
📍 Virtual
✅ Register for the event or reach out to our team at www.scribetx.com/contact
September 23, 2025 at 5:00 PM
This Thursday, join us at the Oppenheimer Private Life Science Company Showcase for a virtual presentation by our CFO David Parrot.
📅 September 25, 2025
🕗 3:15pm ET
📍 Virtual
✅ Register for the event or reach out to our team at www.scribetx.com/contact
📅 September 25, 2025
🕗 3:15pm ET
📍 Virtual
✅ Register for the event or reach out to our team at www.scribetx.com/contact
Knowing your #cholesterol could save your life. This National #CholesterolEducationMonth, stay up to date on the impact cholesterol levels have on your risk for heart disease. 👇
September 19, 2025 at 4:25 PM
Knowing your #cholesterol could save your life. This National #CholesterolEducationMonth, stay up to date on the impact cholesterol levels have on your risk for heart disease. 👇
Attending the Bank of America Healthcare Trailblazers Private Company Conference in Boston this week?
Book a meeting with Scribe CFO David Parrot to learn about our latest updates, data, and approach to advancing #CRISPR for cardiometabolic disease 👉 www.scribetx.com/contact
Book a meeting with Scribe CFO David Parrot to learn about our latest updates, data, and approach to advancing #CRISPR for cardiometabolic disease 👉 www.scribetx.com/contact
September 16, 2025 at 4:00 PM
Attending the Bank of America Healthcare Trailblazers Private Company Conference in Boston this week?
Book a meeting with Scribe CFO David Parrot to learn about our latest updates, data, and approach to advancing #CRISPR for cardiometabolic disease 👉 www.scribetx.com/contact
Book a meeting with Scribe CFO David Parrot to learn about our latest updates, data, and approach to advancing #CRISPR for cardiometabolic disease 👉 www.scribetx.com/contact
📣 Presenting new breakthrough data from two of our core platforms 📣
We're proud to showcase the success of our Lp(a)-lowering therapy STX-1200 and novel #AI platform, DeepXE, for next-generation #CRISPR-based therapeutics.
More details in our link below 👇
We're proud to showcase the success of our Lp(a)-lowering therapy STX-1200 and novel #AI platform, DeepXE, for next-generation #CRISPR-based therapeutics.
More details in our link below 👇
September 9, 2025 at 4:09 PM
📣 Presenting new breakthrough data from two of our core platforms 📣
We're proud to showcase the success of our Lp(a)-lowering therapy STX-1200 and novel #AI platform, DeepXE, for next-generation #CRISPR-based therapeutics.
More details in our link below 👇
We're proud to showcase the success of our Lp(a)-lowering therapy STX-1200 and novel #AI platform, DeepXE, for next-generation #CRISPR-based therapeutics.
More details in our link below 👇
At Scribe, we run on teamwork and purpose – in and out of the lab.
#JPMCC 2025 marked our 4th year participating in the global J.P. Morgan Corporate Challenge. Check out our reel for highlights our team captured as they ran through San Francisco, repping our “ELXR” tech! 🧪😉
#JPMCC 2025 marked our 4th year participating in the global J.P. Morgan Corporate Challenge. Check out our reel for highlights our team captured as they ran through San Francisco, repping our “ELXR” tech! 🧪😉
September 8, 2025 at 6:30 PM
At Scribe, we run on teamwork and purpose – in and out of the lab.
#JPMCC 2025 marked our 4th year participating in the global J.P. Morgan Corporate Challenge. Check out our reel for highlights our team captured as they ran through San Francisco, repping our “ELXR” tech! 🧪😉
#JPMCC 2025 marked our 4th year participating in the global J.P. Morgan Corporate Challenge. Check out our reel for highlights our team captured as they ran through San Francisco, repping our “ELXR” tech! 🧪😉
If you’ll be in New York for the Cantor Global Healthcare Conference, our CEO @benjaminloakes.bsky.social and CFO David Parrot will be on site and available for one-on-one meetings between Sept. 3-5.
Interested in connecting? Reach out through our website 👉 www.scribetx.com/contact
Interested in connecting? Reach out through our website 👉 www.scribetx.com/contact
September 2, 2025 at 4:01 PM
If you’ll be in New York for the Cantor Global Healthcare Conference, our CEO @benjaminloakes.bsky.social and CFO David Parrot will be on site and available for one-on-one meetings between Sept. 3-5.
Interested in connecting? Reach out through our website 👉 www.scribetx.com/contact
Interested in connecting? Reach out through our website 👉 www.scribetx.com/contact
At #ESCCongress for the latest on #CRISPR gene editing treatments for cardiometabolic disease?
On Monday, our CSO Aarif Khakoo will present late-breaking preclinical data on STX-1200, our novel CRISPR-CasX based gene editing therapy to reduce elevated Lp(a) & CVD risk. Read more 👇
On Monday, our CSO Aarif Khakoo will present late-breaking preclinical data on STX-1200, our novel CRISPR-CasX based gene editing therapy to reduce elevated Lp(a) & CVD risk. Read more 👇
August 29, 2025 at 4:03 PM
At #ESCCongress for the latest on #CRISPR gene editing treatments for cardiometabolic disease?
On Monday, our CSO Aarif Khakoo will present late-breaking preclinical data on STX-1200, our novel CRISPR-CasX based gene editing therapy to reduce elevated Lp(a) & CVD risk. Read more 👇
On Monday, our CSO Aarif Khakoo will present late-breaking preclinical data on STX-1200, our novel CRISPR-CasX based gene editing therapy to reduce elevated Lp(a) & CVD risk. Read more 👇
This fall, we are thrilled to present our latest updates on our #CRISPR genetic and epigenetic editing therapies, new machine learning approach, and corporate strategy at several premier conferences.
If you’ll be at #ECCongress, #CGMesa25, and others, read on for more details 👇
If you’ll be at #ECCongress, #CGMesa25, and others, read on for more details 👇
August 25, 2025 at 1:07 PM
This fall, we are thrilled to present our latest updates on our #CRISPR genetic and epigenetic editing therapies, new machine learning approach, and corporate strategy at several premier conferences.
If you’ll be at #ECCongress, #CGMesa25, and others, read on for more details 👇
If you’ll be at #ECCongress, #CGMesa25, and others, read on for more details 👇
Deep learning for #CRISPR?
We're presenting "DeepXE" at @cshlnews.bsky.social's Genome Engineering: CRISPR Frontiers meeting—the 1st predictive model for on-target activity of our genome editor engineered from CasX.
Learn how we're tapping #AI to design efficient gRNAs for therapeutics. #CSHL
We're presenting "DeepXE" at @cshlnews.bsky.social's Genome Engineering: CRISPR Frontiers meeting—the 1st predictive model for on-target activity of our genome editor engineered from CasX.
Learn how we're tapping #AI to design efficient gRNAs for therapeutics. #CSHL
August 11, 2025 at 4:31 PM
Deep learning for #CRISPR?
We're presenting "DeepXE" at @cshlnews.bsky.social's Genome Engineering: CRISPR Frontiers meeting—the 1st predictive model for on-target activity of our genome editor engineered from CasX.
Learn how we're tapping #AI to design efficient gRNAs for therapeutics. #CSHL
We're presenting "DeepXE" at @cshlnews.bsky.social's Genome Engineering: CRISPR Frontiers meeting—the 1st predictive model for on-target activity of our genome editor engineered from CasX.
Learn how we're tapping #AI to design efficient gRNAs for therapeutics. #CSHL
📣 New publication alert! Scribe and @ucberkeleyofficial.bsky.social scientists (Zachary Miller, Lokesh Narsineni et al.) have a paper out in the Journal of Controlled Release on a powerful new method for molecular characterization of lipid nanoparticles and mRNA packaging.
Learn more below ⬇️
Learn more below ⬇️
August 8, 2025 at 4:06 PM
📣 New publication alert! Scribe and @ucberkeleyofficial.bsky.social scientists (Zachary Miller, Lokesh Narsineni et al.) have a paper out in the Journal of Controlled Release on a powerful new method for molecular characterization of lipid nanoparticles and mRNA packaging.
Learn more below ⬇️
Learn more below ⬇️
What if your DNA didn’t define your health destiny?
In his TEDx Talk, our CEO @benjaminloakes.bsky.social reimagines a future where anyone could walk into their doctor’s office, get treated once, and walk out healthier for life – thanks to next-generation CRISPR-based therapies.
In his TEDx Talk, our CEO @benjaminloakes.bsky.social reimagines a future where anyone could walk into their doctor’s office, get treated once, and walk out healthier for life – thanks to next-generation CRISPR-based therapies.
July 28, 2025 at 5:32 PM
What if your DNA didn’t define your health destiny?
In his TEDx Talk, our CEO @benjaminloakes.bsky.social reimagines a future where anyone could walk into their doctor’s office, get treated once, and walk out healthier for life – thanks to next-generation CRISPR-based therapies.
In his TEDx Talk, our CEO @benjaminloakes.bsky.social reimagines a future where anyone could walk into their doctor’s office, get treated once, and walk out healthier for life – thanks to next-generation CRISPR-based therapies.
Kick off #BIO2025 week with our CBO Svetlana Lucas as she joins biopharma leaders to discuss what makes a platform or modality partnerable—to ultimately bring next-generation therapies to patients.
More details 👉 convention.bio.org/program-1/jo...
More details 👉 convention.bio.org/program-1/jo...
June 11, 2025 at 5:30 PM
Kick off #BIO2025 week with our CBO Svetlana Lucas as she joins biopharma leaders to discuss what makes a platform or modality partnerable—to ultimately bring next-generation therapies to patients.
More details 👉 convention.bio.org/program-1/jo...
More details 👉 convention.bio.org/program-1/jo...
We're excited to attend #BIO2025!
Reach out to set up a meeting with us if you're interested in collaborating to rewrite the story of disease and hearing the latest updates on our #CRISPR genome and epigenome editing technologies and pipeline 👉 www.scribetx.com/contact
Reach out to set up a meeting with us if you're interested in collaborating to rewrite the story of disease and hearing the latest updates on our #CRISPR genome and epigenome editing technologies and pipeline 👉 www.scribetx.com/contact
June 3, 2025 at 9:17 PM
We're excited to attend #BIO2025!
Reach out to set up a meeting with us if you're interested in collaborating to rewrite the story of disease and hearing the latest updates on our #CRISPR genome and epigenome editing technologies and pipeline 👉 www.scribetx.com/contact
Reach out to set up a meeting with us if you're interested in collaborating to rewrite the story of disease and hearing the latest updates on our #CRISPR genome and epigenome editing technologies and pipeline 👉 www.scribetx.com/contact